SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: wiz who wrote (138)12/1/1999 10:41:00 AM
From: Brian Malloy  Read Replies (1) of 250
 
Just saying that based on what happened in the early 90's when several biotechs collapsed once it became obvious that nothing/very little was going to emerge through the pipeline. By way of example, I can remember XOMA trading in the $20-$30 range or so in 1991. By '92 it was in the single digits and goes for $3 or so now.

Just consider $3 as a terminal value for biotechs that are relegated to the junk heap. You can spend countless hours trying to quantify the near unquantifiable or go with the 90% solution.

IMHO
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News